Stronger Sell Today FOLD ranks #4455 as SELL CANDIDATE. Weaker Sell
Today FOLD ranks #4455 as SELL CANDIDATE.

FOLD stock Amicus Therapeutics

FOLD stock
Amicus Therapeutics

April 24, 2019
Change -1.05%
Chart period: 2019-01-25 - 2019-04-24





Will FOLD stock price go up or down on Thu, 25 Apr 2019?

Amicus Therapeutics Forecast and Stock Analysis

Technical FOLD stock analysis for April 24, 2019.

Sell candidate since 2019-04-24
Shorts n/a
Cash n/a
Loans n/a
Beta 1.79
ROA n/a

Amicus Therapeutics fell by -1.05% in the last day from $13.29 to $13.15 The price has fallen in 5 of the last 10 days and is down by -6.07% for this period. Volume has increased in the last day by 0.10 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 3.54 million shares bought and sold for approximately $46.61 million.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the FOLD stock was $13.15. This is 1.05% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 3.32% from a day low at $12.94 to a day high of $13.37.

30 day high of the FOLD stock price was $14.62 and low was $12.39.
90 day high was $14.62 and low was $10.30.
52 week high for the Amicus Therapeutics - $17.62 and low - $8.27.


Amicus Therapeutics lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $12.83 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 21.39% during the next 3 months and, with 90% probability hold a price between $15.57 and $18.92 at the end of this period.

Click here for today's Top 5 Trending Companies


There are few to none technical positive signals at the moment. Amicus Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $13.53. On a fall, the stock will find some support from the short-term average at $13.12. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 38 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amicus Therapeutics finds support from accumulated volume at $12.69.

Support: $12.69 Price: $13.15 Resistance: $13.92


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.43 (3.32%) between high and low. For the last week, the stock has had a daily average volatility of 5.49%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

The Amicus Therapeutics stock holds several negative signals and despite the positive trend we believe Amicus Therapeutics will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Stronger Sell Today FOLD ranks #4455 as SELL CANDIDATE. Weaker Sell
Today FOLD ranks #4455 as SELL CANDIDATE.